Skip to content

Brain-Derived Neurotrophic Factor level in Depressive patients

Evaluation of the effectc of the synchronised exercise and electroconvalsive therapy on serum brain neurotherupic factor in drug resistance depressive patient

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201312271743N12
Enrollment
60
Registered
2014-01-07
Start date
2013-01-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Depressive Disorder. Depressive episode

Interventions

Intervention 1: Electero Convulsive Therapy+ antidepressant drug. Intervention 2: exercise +antidepressant. Intervention 3: Antidepressant drug.
Treatment - Drugs
Electero Convulsive Therapy+ antidepressant drug
exercise +antidepressant
Antidepressant drug

Sponsors

Research center for behavioral disorders and substance abuse, Hamadan university of medical sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusive Criteria 1. Patients with unipolar major depressive disorder admitted in one of the psychiatric wards of Farshchian Hospital 2. Aged of 18-40 years 3. No systemic diseases such as diabetes, hypertension, epilepsy and etc 4. No history of alcohol abuse or other illegal substances 5. Patient’s informed consent Exclusive Criteria 1. Incidence of uncontrollable somatic condition 2. Patient’s unwillingness to continue participation

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Severity of symptoms of Depression. Timepoint: Baseline and 4 weeks after treatment. Method of measurement: Hamiltone Depression scale.;Level of Brain-derived neurotrophic factor in serum. Timepoint: Baseline and 4 weeks after treatment. Method of measurement: ELISA.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Haghighi

Research center for behavioral disorders and substance abuse, Hamadan university of medical sciences

haghighi@umsha.ac.ir+98 81 1827 1066

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026